Mayo Clinic to host clinical research conference

August 06, 2003

ROCHESTER, Minn. -- Mayo Alliance for Clinical Trials will host "Current Issues in Clinical Research: How Education, Certification and Validation Will Improve the Quality of Research," Sept. 25-26, 2003, at the Mayo Civic Center in Rochester, Minn.

The conference is designed for study coordinators, nurses, physicians and other research personnel involved in the management and coordination of clinical research, and will provide a comprehensive review of the responsibilities and processes of clinical research performance. The conference format balances topics of general interest, which are presented in large group sessions, with clinical research and management issues addressed in small breakout sessions.

At the end of the conference, participants should be able to:Guest faculty scheduled to present at the conference include:The conference will provide a review of the mechanics of clinical research coordination and has been approved for multiple forms of credit.

The conference will be held in Presentation Hall, Mayo Civic Center, 30 Civic Center Drive S.E. in Rochester. The registration fee is $450.

For more information or to register, contact the Mayo Clinic Education Office at 800-541-5815 or 507-266-3074, or visit the Mayo Clinical Trial Services Web site at
Nicole Bennett
507-284-5005 (days)
507-284-2511 (evenings)

Mayo Clinic

Related Clinical Trials Articles from Brightsurf:

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic.

COVID-19 clinical trials lack diversity
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Why we should trust registered clinical trials
In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

Inclusion of children in clinical trials of treatments for COVID-19
This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.

Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.

Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.

Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.

When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.

New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.

Read More: Clinical Trials News and Clinical Trials Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to